10-46585670-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 1P and 0B. PP3
The NM_031912.5(SYT15):c.1016G>A(p.Gly339Asp) variant causes a missense change. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 8)
Exomes 𝑓: 0.0000050 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
SYT15
NM_031912.5 missense
NM_031912.5 missense
Scores
2
3
4
Clinical Significance
Conservation
PhyloP100: 7.12
Genes affected
SYT15 (HGNC:17167): (synaptotagmin 15) This gene encodes a member of the Synaptotagmin (Syt) family of membrane trafficking proteins. Members of this family contain a transmembrane region and a C-terminal-type tandem C2 domain. Unlike related family members, the encoded protein may be involved in membrane trafficking in non-neuronal tissues. Two trancript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.761
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 8
GnomAD3 genomes
Cov.:
8
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000495 AC: 1AN: 201904Hom.: 0 Cov.: 0 AF XY: 0.00000959 AC XY: 1AN XY: 104274
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
1
AN:
201904
Hom.:
Cov.:
0
AF XY:
AC XY:
1
AN XY:
104274
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 8
GnomAD4 genome
Cov.:
8
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 27, 2024 | The c.1016G>A (p.G339D) alteration is located in exon 7 (coding exon 7) of the SYT15 gene. This alteration results from a G to A substitution at nucleotide position 1016, causing the glycine (G) at amino acid position 339 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_noAF
Pathogenic
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T;.;.
LIST_S2
Benign
.;T;.;T
MetaRNN
Pathogenic
D;D;D;D
PROVEAN
Uncertain
D;D;D;D
Sift
Benign
T;D;D;D
Sift4G
Uncertain
D;T;T;D
Vest4
gMVP
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.